Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations section was reorganized: explicit per-state locations (e.g., California, Colorado, Florida, etc.) were removed and replaced with a general 'Locations' heading listing regions, accompanied by a revision tag update from v3.3.2 to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T08:28:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Removed the 'Certification/Extension First Posted' entry from the Study Record Dates. Other date entries, such as First Submitted and Last Update, remain shown.
    Difference
    0.1%
    Check dated 2025-12-08T22:31:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label in the site footer updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T16:38:24.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.1; removed the older PubMed-sourced sentence and the Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T11:57:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Deleted the government funding/operating status notice that used to appear at the bottom of the page. The notice described potential delays in updates and NIH facility operations.
    Difference
    0.4%
    Check dated 2025-11-17T06:18:43.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    External links to PubMed and U.S. government sites were removed from the page footer. The core study details and page structure remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T00:57:26.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.